205 related articles for article (PubMed ID: 30381291)
1. LTRs activated by Epstein-Barr virus-induced transformation of B cells alter the transcriptome.
Leung A; Trac C; Kato H; Costello KR; Chen Z; Natarajan R; Schones DE
Genome Res; 2018 Dec; 28(12):1791-1798. PubMed ID: 30381291
[TBL] [Abstract][Full Text] [Related]
2. Enhancer Control of MicroRNA miR-155 Expression in Epstein-Barr Virus-Infected B Cells.
Wood CD; Carvell T; Gunnell A; Ojeniyi OO; Osborne C; West MJ
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021904
[TBL] [Abstract][Full Text] [Related]
3. Induction of interferon-stimulated genes on the IL-4 response axis by Epstein-Barr virus infected human b cells; relevance to cellular transformation.
Smith N; Tierney R; Wei W; Vockerodt M; Murray PG; Woodman CB; Rowe M
PLoS One; 2013; 8(5):e64868. PubMed ID: 23724103
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome.
Szymula A; Palermo RD; Bayoumy A; Groves IJ; Ba Abdullah M; Holder B; White RE
PLoS Pathog; 2018 Feb; 14(2):e1006890. PubMed ID: 29462212
[TBL] [Abstract][Full Text] [Related]
5. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
Nilsson T; Sjöblom A; Masucci MG; Rymo L
Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
7. Restricted TET2 Expression in Germinal Center Type B Cells Promotes Stringent Epstein-Barr Virus Latency.
Wille CK; Li Y; Rui L; Johannsen EC; Kenney SC
J Virol; 2017 Mar; 91(5):. PubMed ID: 28003489
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus induces global changes in cellular mRNA isoform usage that are important for the maintenance of latency.
Homa NJ; Salinas R; Forte E; Robinson TJ; Garcia-Blanco MA; Luftig MA
J Virol; 2013 Nov; 87(22):12291-301. PubMed ID: 24027308
[TBL] [Abstract][Full Text] [Related]
9. Intracellular forms of human NOTCH1 functionally activate essential Epstein-Barr virus major latent promoters in the Burkitt's lymphoma BJAB cell line but repress these promoters in Jurkat cells.
Cotter M; Callahan J; Aster J; Robertson E
J Virol; 2000 Feb; 74(3):1486-94. PubMed ID: 10627560
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional activation signals found in the Epstein-Barr virus (EBV) latency C promoter are conserved in the latency C promoter sequences from baboon and Rhesus monkey EBV-like lymphocryptoviruses (cercopithicine herpesviruses 12 and 15).
Fuentes-Pananá EM; Swaminathan S; Ling PD
J Virol; 1999 Jan; 73(1):826-33. PubMed ID: 9847397
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes.
Schmidt SC; Jiang S; Zhou H; Willox B; Holthaus AM; Kharchenko PV; Johannsen EC; Kieff E; Zhao B
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):554-9. PubMed ID: 25540416
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Virus Episome Physically Interacts with Active Regions of the Host Genome in Lymphoblastoid Cells.
Wang L; Laing J; Yan B; Zhou H; Ke L; Wang C; Narita Y; Zhang Z; Olson MR; Afzali B; Zhao B; Kazemian M
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999023
[TBL] [Abstract][Full Text] [Related]
13. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
[TBL] [Abstract][Full Text] [Related]
14. Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.
Hutchings IA; Tierney RJ; Kelly GL; Stylianou J; Rickinson AB; Bell AI
J Virol; 2006 Nov; 80(21):10700-11. PubMed ID: 16920819
[TBL] [Abstract][Full Text] [Related]
15. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter.
Zimber-Strobl U; Kremmer E; Grässer F; Marschall G; Laux G; Bornkamm GW
EMBO J; 1993 Jan; 12(1):167-75. PubMed ID: 8381349
[TBL] [Abstract][Full Text] [Related]
16. EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes.
Su C; Lu F; Soldan SS; Lamontagne RJ; Tang HY; Napoletani G; Farrell PJ; Tempera I; Kossenkov AV; Lieberman PM
PLoS Pathog; 2021 Aug; 17(8):e1009834. PubMed ID: 34352044
[TBL] [Abstract][Full Text] [Related]
17. Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter down-regulation during virus-induced B-cell transformation.
Tierney RJ; Kirby HE; Nagra JK; Desmond J; Bell AI; Rickinson AB
J Virol; 2000 Nov; 74(22):10468-79. PubMed ID: 11044091
[TBL] [Abstract][Full Text] [Related]
18. Epstein - Barr virus transforming protein LMP-1 alters B cells gene expression by promoting accumulation of the oncoprotein ΔNp73α.
Accardi R; Fathallah I; Gruffat H; Mariggiò G; Le Calvez-Kelm F; Voegele C; Bartosch B; Hernandez-Vargas H; McKay J; Sylla BS; Manet E; Tommasino M
PLoS Pathog; 2013 Mar; 9(3):e1003186. PubMed ID: 23516355
[TBL] [Abstract][Full Text] [Related]
19. Dominant-negative derivative of EBNA1 represses EBNA1-mediated transforming gene expression during the acute phase of Epstein-Barr virus infection independent of rapid loss of viral genome.
Kariya Y; Hamatake M; Urano E; Yoshiyama H; Shimizu N; Komano J
Cancer Sci; 2010 Apr; 101(4):876-81. PubMed ID: 20132216
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus nuclear antigen 2 (EBNA2)-oestrogen receptor fusion proteins complement the EBNA2-deficient Epstein-Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma lines.
Kempkes B; Zimber-Strobl U; Eissner G; Pawlita M; Falk M; Hammerschmidt W; Bornkamm GW
J Gen Virol; 1996 Feb; 77 ( Pt 2 )():227-37. PubMed ID: 8627226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
